Sphingolipid profile in tracheal aspirates as a new biomarker for the development of bronchopulmonary dysplasia

Sphingolipid profile in tracheal aspirates as a new biomarker for the development of bronchopulmonary dysplasia - SPIN = Sphingolipid Profiles In Neonates

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38716

Enrollment

150

Registered

2013-07-09

Start date

2013-09-23

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary dysplasia Chronic lung disease of prematurity

Interventions

None listed

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Infants born

Exclusion criteria

Exclusion criteria: Infants born with a congenital disease that might affect lung structure and/or -function. Infants who are treated according to the INSURE procedure.

Design outcomes

Primary

Measure	Time frame
Profiles of sphingolipids and oxylipins in tracheal aspirates of prematurely born infants with and without BPD.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results